Nassif, Michael
Kosiborod, Mikhail
Article History
First Online: 25 January 2018
Competing interests
: M.K. declares that he is on the advisory boards for Amgen, AstraZeneca, Boehringer Ingelheim, Eisai, Glytec, GSK, Merck, Novo Nordisk, Sanofi, and ZS Pharma; is a consultant for AstraZeneca, Sanofi, and ZS Pharma; and has received research grants from AstraZeneca and Boehringer Ingelheim. M.N. declares no competing interests.